Capillary Technologies reports ₹95.5m loss in Q1FY27 amid cyber fraud hit

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

Capillary Technologies India Limited posted a Q1FY27 consolidated net loss of ₹95.5 million, primarily attributed to an exceptional cyber fraud expense of ₹333.9 million. Despite this, the company's core operations performed strongly, with revenue from operations rising 43% YoY to ₹2,566.4 million. Subscription revenue, constituting 94.5% of total income, grew by 50% to ₹2,424.9 million. Normalized PAT was ₹254.4 million, reflecting a 10% margin and significant operational improvement.

powered bylight_fuzz_icon
47376442

*this image is generated using AI for illustrative purposes only.

Capillary Technologies India Limited reported a consolidated net loss of ₹95.5 million for the quarter ended June 30, 2026 (Q1FY27), primarily due to an exceptional cyber fraud loss of ₹333.9 million. Despite the headline loss, the company’s core operations showed significant strength, with revenue from operations surging 43% year-on-year to ₹2,566.4 million, driven by a 50% increase in subscription revenue. The Board of Directors approved the unaudited financial results on August 4, 2026, following a limited review by statutory auditors Walker Chandiok & Co LLP under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The divergence between the standalone profitability and consolidated loss highlights the isolated nature of the exceptional item. While the standalone entity posted a net profit of ₹77.65 million, the group-level results were heavily impacted by the one-time fraud expense and a deferred tax liability of ₹16.1 million. Excluding these non-operational items, the company’s normalized profit after tax (PAT) stood at ₹254.4 million, representing a 10% margin and a substantial year-on-year growth of 3,320% compared to the previous year’s normalized PAT.

Consolidated Financial Performance

Consolidated EBITDA rose 142% year-on-year to ₹460.1 million, with an EBITDA margin of 18%, up from 11% in Q1FY26. Adjusted EBITDA, which excludes ESOP expenses and finance income/gains, increased 132% to ₹440.2 million, maintaining a margin of 17%. Total expenses grew 32% to ₹2,126.5 million, reflecting higher investments in cloud infrastructure and employee benefits, including ESOP expenses of ₹36.9 million.

Particulars Q1FY27 (₹ million) Q1FY26 (₹ million) YoY Change
Revenue from operations 2,566.4 1,798.9 43%
Total Expenses 2,126.5 1,609.2 32%
EBITDA 460.1 189.9 142%
Adjusted EBITDA 440.2 189.7 132%
Profit/(Loss) After Tax (95.5) 7.5 -

Subscription Revenue Growth

Subscription revenue, which constitutes the core of Capillary’s business model, grew by ₹809 million year-on-year to ₹2,424.9 million in Q1FY27, accounting for 94.5% of total revenue. This robust growth underscores the increasing adoption of the company’s customer engagement platform. Other services, including installation fees, contributed ₹122.4 million (4.8%), while campaign services added ₹19.2 million (0.7%). The shift towards a higher mix of recurring subscription revenue indicates improved business stability and predictability.

Capital Efficiency and Returns

The company demonstrated improved capital efficiency, with Return on Invested Capital (ROIC) rising to 7.3% in the trailing twelve months ended June 30, 2026, compared to 4.8% in FY26. Cash Return on Invested Capital (CROIC) also strengthened to 23.2%, up from 21.8% in FY26. Capital employed remained stable at ₹10,676.2 million, while invested capital increased to ₹5,986.2 million from ₹5,494.0 million in FY26, reflecting strategic deployment of funds towards growth initiatives.

What the Numbers Show

The key takeaway from Q1FY27 is the resilience of Capillary’s core business against exceptional headwinds. The normalized PAT of ₹254.4 million reveals a healthy underlying profitability that was obscured by the ₹333.9 million cyber fraud loss. The 50% growth in subscription revenue highlights successful execution of its go-to-market strategy and integration of recent acquisitions like SessionM. Investors should monitor the trajectory of adjusted EBITDA margins, which have expanded from 11% to 17% year-on-year, signaling operational leverage as the company scales. The heavy reliance on subscription revenue (94.5%) reduces volatility but requires continuous innovation to maintain high net retention rates.

Historical Stock Returns for Capillary Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-1.46%-1.08%-6.31%-2.44%0.0%0.0%

What specific cybersecurity enhancements or insurance measures is Capillary implementing to mitigate the risk of future fraud losses following the ₹333.9 million incident?

How will the integration of SessionM impact Capillary's net retention rates and customer acquisition costs in the upcoming quarters?

Given the 32% rise in total expenses driven by cloud infrastructure, will Capillary be able to sustain its expanded 17% adjusted EBITDA margin as it scales further?

like15
dislike

Capillary Technologies Q1 Results: Earnings call audio released

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

Capillary Technologies India Limited disclosed the availability of its Q1FY27 earnings call audio recording on August 04, 2026. The move complies with SEBI Listing Regulations, ensuring investors have access to management's commentary on the quarter's performance. The filing was processed by Company Secretary Gireddy Bhargavi Reddy.

powered bylight_fuzz_icon
47405788

*this image is generated using AI for illustrative purposes only.

Capillary Technologies has released the audio recording of its earnings conference call with analysts and investors, providing transparency into its financial performance discussions. The call took place on Tuesday, August 04, 2026, allowing stakeholders to review management's commentary on the company's operational and financial results for the period.

The disclosure was made in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Capillary Technologies submitted the details to both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE) on August 04, 2026.

Compliance Details

The company ensured that the audio recording is accessible to the public via its official website, adhering to regulatory mandates for timely disclosure. The filing was signed by Gireddy Bhargavi Reddy, the Company Secretary and Compliance Officer of Capillary Technologies India Limited.

Detail Information
Event Earnings Conference Call
Date Held August 04, 2026
Regulation SEBI LODR Regulation 30
Exchange BSE, NSE
Signatory Gireddy Bhargavi Reddy

Accessing the Recording

Investors and analysts can access the full audio recording through the link provided on the company's website. This resource serves as a primary source for understanding the nuances of the company's performance beyond the written financial statements. The recording covers questions from analysts regarding the company's strategic direction and financial health.

What the Numbers Show

While this filing primarily concerns the availability of the earnings call audio, it underscores the company's commitment to regulatory compliance and investor communication. The release of such recordings allows market participants to gauge management sentiment and clarify any ambiguities present in the formal financial results. For detailed financial metrics such as revenue, net profit, or EBITDA, investors are directed to the separate financial results filing or the transcript of the aforementioned call.

Historical Stock Returns for Capillary Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-1.46%-1.08%-6.31%-2.44%0.0%0.0%

How might management's commentary on strategic direction during the August 4 call influence Capillary Technologies' near-term stock valuation and investor sentiment?

What specific operational challenges or growth opportunities highlighted in the earnings call could impact the company's revenue trajectory in the upcoming fiscal quarters?

Given the emphasis on regulatory compliance, are there any pending SEBI inquiries or governance changes that could affect Capillary Technologies' operational flexibility?

like16
dislike

More News on Capillary Technologies

1 Year Returns:0.00%